BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Duke-NUS and GenScript notice of allowance for U.S. patent application for SARS-CoV-2 surrogate virus neutralisation test

Developed by Professor Linfa Wang and his team from Duke-NUS, the sVNT neutralization antibody detection technology is exclusively licensed to Ge...

June 25, 2021 | News

China's first CAR-T Cell Therapy (FKC876) approved

The first* CAR-T cell therapy approved by NMPA: opening a new era of cell therapy in China Individualized living-cell-based medicine: genetica...

June 24, 2021 | News

Merck Receives Patent for Improved CRISPR Genome-Editing Method in Japan

Proxy-CRISPR technology provides solution to improve genome editing and advance new possibilities for research Helps modify difficult-to-access regions ...

June 23, 2021 | News

eTheRNA and VUB expand strategic collaboration to engineer next generation mRNA therapeutics with TetraMix®

eTheRNA immunotherapies NV a clinical-stage company developing mRNA-based immunotherapies for the treatment of cancer and infectious diseases, announ...

June 23, 2021 | News

Innovent Biologics Announces the Approval of Pemazyre® (pemigatinib) in Taiwan Market

Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medi...

June 22, 2021 | News

MSD Announces Supply Agreement with U.S. Govt. for Molnupiravir

Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced it has entered into a procurement agreement with&...

June 21, 2021 | News

CARsgen Therapeutics officially listing on HKEX

CARsgen Therapeutics Holdings Limited (the "Company", stock code: 2171.HK) today announced that the Company's Shares have been traded on the Main Board of ...

June 19, 2021 | News

Totient, a Viva Biotech Portfolio Company, has been Acquired by AbSci

Viva Biotech (01873.HK) declared today that Totient, one of its portfolio companies, has been acquired by AbSci, a synthetic biology company unlocking the ...

June 16, 2021 | News

Novavax COVID-19 Vaccine Demonstrates 90% Overall Efficacy

93% efficacy against predominantly circulating Variants of Concern and Variants of Interest 91% efficacy in high-risk populations 100% efficacy against...

June 15, 2021 | News

Chinese biotech firm Vazyme to showcase full range of COVID-19 Testing Solutions at Medlab

Medlab has become a world-famous laboratory exhibition and a globally-recognized professional IVD expo with international stature. Last year alone, the eve...

June 15, 2021 | News

VERAXA Biotech and Quadira Biosciences Enter Partnership on ADC Development

The collaboration will leverage both the advantages of VERAXA's advanced and proprietary position-true click-chemistry-based drug conjugation technology in...

June 14, 2021 | News

Theramex UK Ltd announces a license and supply agreement with Enzene Biosciences Limited

Theramex UK Ltd announces a license and supply agreement with Enzene Biosciences Limited, for the registration and commercialisation of denosumab, an antir...

June 10, 2021 | News

Hummingbird Bioscience and Novogene to expand precision medicine testing

Partnership will enhance biomarker-driven patient enrollment in clinical trials of Hummingbird Bioscience's lead program, HMBD-001 Hummingbird Bioscience,...

June 09, 2021 | News

Essent Biologics Launches Human Mesenchymal Stem Cells

Essent Biologics will provide highly-characterized, low-passaged hMSCs. Each vial will contain over one million cells at thaw and have a passage level of P...

June 09, 2021 | News

Stay Connected